09 Nov Identification of blood immune biomarkers as surrogate measures of CDK4/6i treatment efficacy in ER+HER2- advanced breast cancer

Posted at 02:18h in Tumour- microenvironment crosstalk by

ID: 2523

Autores: Cabrero De Las Heras, Sara (0); Cabrero-De Las Heras, Sara (1); Felip, Eudald (1,2); Quiroga, Vanessa (2); Riveira-Muñoz, Eva (1); Cirauqui, Beatriz (2); Badia, Roger (1); Gutierrez-Chamorro, Lucía (1); Teruel, Iris (2); Ferrando, Angelica (2); Pous, Anna (2); Ballana, Ester (1,3); Margelí, Mieia (2,3)

Temática: Tumour- microenvironment crosstalk